Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Montelukast in Modulation of Response to Sepsis in Preterm Infants

NCT04474327 is registered in ClinicalTrials.gov with Mansoura University Children Hospital as lead sponsor.

NCT NCT04474327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04474327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Montelukast in Modulation of Response to Sepsis in Preterm Infants
Lead sponsor
Mansoura University Children Hospital
Phase
Phase 1
Overall status
Completed
Start date
July 24, 2020
Completion date
February 10, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis